{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:04Z","timestamp":1793394964228,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"crossref","award":["5R01NS086746-04"],"award-info":[{"award-number":["5R01NS086746-04"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11064-019-02809-1","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T20:50:50Z","timestamp":1557262250000},"page":"2423-2434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["PGC-1\u03b1, Sirtuins and PARPs in Huntington\u2019s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-9664","authenticated-orcid":false,"given":"Alejandro","family":"Lloret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"2809_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"2809_CR2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","volume":"21","author":"A Johri","year":"2012","unstructured":"Johri A, Calingasan NY, Hennessey T, Sharma A, Yang L, Wille E, Chandra A, Beal MF (2012) Pharamcologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 21:1124\u20131137","journal-title":"Hum Mol Genet"},{"key":"2809_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00415-018-8940-6","volume":"266","author":"S Podvin","year":"2018","unstructured":"Podvin S, Reardon HT, Yin K, Mosier C, Hook V (2018) Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. J Neurol 266:551\u2013564","journal-title":"J Neurol"},{"issue":"3","key":"2809_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12041-018-0957-1","volume":"97","author":"M Pandey","year":"2018","unstructured":"Pandey M, Rajamma U (2018) Huntington\u2019s disease: the coming of age. J Genet 97(3):649\u2013664","journal-title":"J Genet"},{"issue":"23","key":"2809_CR5","doi-asserted-by":"crossref","first-page":"R1256","DOI":"10.1016\/j.cub.2017.09.054","volume":"27","author":"AKL Leung","year":"2017","unstructured":"Leung AKL (2017) PARPs. Curr Biol 27(23):R1256\u2013R1258","journal-title":"Curr Biol"},{"issue":"6","key":"2809_CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92(6):829\u2013839","journal-title":"Cell"},{"issue":"1","key":"2809_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11154-013-9273-5","volume":"15","author":"GC Rowe","year":"2014","unstructured":"Rowe GC, Arany Z (2014) Genetic models of PGC-1 and glucose metabolism and homeostasis. Rev Endocr Metab Disord 15(1):21\u201329","journal-title":"Rev Endocr Metab Disord"},{"issue":"6852","key":"2809_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35093131","volume":"413","author":"S Herzig","year":"2001","unstructured":"Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, PuigserverP Spiegelman B, Montminy M (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413(6852):179\u2013183","journal-title":"Nature"},{"issue":"6852","key":"2809_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","volume":"413","author":"JC Yoon","year":"2001","unstructured":"Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413(6852):131\u2013138","journal-title":"Nature"},{"issue":"6","key":"2809_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","volume":"1","author":"J Lin","year":"2005","unstructured":"Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1(6):361\u2013370","journal-title":"Cell Metab"},{"issue":"12","key":"2809_CR11","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","volume":"100","author":"C Handschin","year":"2003","unstructured":"Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 100(12):7111\u20137116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2809_CR12","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1074\/jbc.M501485200","volume":"280","author":"S Nemoto","year":"2005","unstructured":"Nemoto S, Fergusson MM, Finkel T (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1\u03b1. J Biol Chem 280(16):16456\u201316460","journal-title":"J Biol Chem"},{"issue":"2","key":"2809_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000332326","volume":"49","author":"CC Beeson","year":"2012","unstructured":"Beeson CC, Beeson GC, Buff H, Eldridge J, Zhang A, Seth A, Demcheva M, Vournakis JN, Muise-Helmericks RC (2012) Integrin-dependent Akt1 activation regulates PGC-1 expression and fatty acid oxidation. Vasc Res 49(2):89\u2013100","journal-title":"Vasc Res"},{"issue":"1","key":"2809_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2009.11.006","volume":"11","author":"JT Rodgers","year":"2010","unstructured":"Rodgers JT, Haas W, Gygi SP, Puigserver P (2010) Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis. Cell Metab 11(1):23\u201334","journal-title":"Cell Metab"},{"issue":"21","key":"2809_CR15","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1093\/hmg\/ddn230","volume":"17","author":"N Zhong","year":"2008","unstructured":"Zhong N, Xu J (2008) Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1alpha: regulation by SUMOylation and oxidation. Hum Mol Genet 17(21):3357\u20133367","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2809_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cmet.2006.04.013","volume":"3","author":"C Lerin","year":"2006","unstructured":"Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P (2006) GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 3(6):429\u2013438","journal-title":"Cell Metab"},{"issue":"39","key":"2809_CR17","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.0606714103","volume":"103","author":"Z Wu","year":"2006","unstructured":"Wu Z, Huang X, Feng Y, Handschin C, Feng Y, Gullicksen PS, Bare O, Labow M, Spiegelman B, Stevenson SC (2006) Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci U S A 103(39):14379\u201314384","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"2809_CR18","doi-asserted-by":"crossref","first-page":"44495","DOI":"10.1074\/jbc.M105945200","volume":"276","author":"PM Barger","year":"2001","unstructured":"Barger PM, Browning AC, Garner AN, Kelly DP (2001) p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 276(48):44495\u201344501","journal-title":"J Biol Chem"},{"issue":"5","key":"2809_CR19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1097-2765(01)00390-2","volume":"8","author":"P Puigserver","year":"2001","unstructured":"Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB, Spiegelman BM (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8(5):971\u2013982","journal-title":"Mol Cell"},{"issue":"29","key":"2809_CR20","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","volume":"104","author":"S J\u00e4ger","year":"2007","unstructured":"J\u00e4ger S, Handschin C, St-Pierre J, Spiegelman BM (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104(29):12017\u201312022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2809_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-1","volume":"6","author":"HV Che","year":"2011","unstructured":"Che HV, Metzger S, Portal E, Deyle C, Riess O, Nguyen HP (2011) Localization of sequence variations in PGC-1\u03b1 influence their modifying effect in Huntington disease. Mol Neurodegener 6(1):1","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2809_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-6-32","volume":"6","author":"E Taherzadeh-Fard","year":"2011","unstructured":"Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L (2011) PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 6(1):32","journal-title":"Mol Neurodegener"},{"issue":"15","key":"2809_CR23","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/dds177","volume":"21","author":"SM Soyal","year":"2012","unstructured":"Soyal SM, Felder TK, Auer S, Hahne P, Oberkofler H, Witting A, Paulmichl M, Landwehrmeyer GB, Weydt P, Patsch W, Network European Huntington Disease (2012) A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet 21(15):3461\u20133473","journal-title":"Hum Mol Genet"},{"key":"2809_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-14-1","volume":"14","author":"P Weydt","year":"2014","unstructured":"Weydt P, Soyal SM, Landwehrmeyer GB, Patsch W, Network European Huntington Disease (2014) A single nucleotide polymorphism in the coding region of PGC-1\u03b1 is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol 14:1","journal-title":"BMC Neurol"},{"issue":"1","key":"2809_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","volume":"119","author":"J Lin","year":"2004","unstructured":"Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, J\u00e4ger S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119(1):121\u2013135","journal-title":"Cell"},{"issue":"4","key":"2809_CR26","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","volume":"3","author":"TC Leone","year":"2005","unstructured":"Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3(4):e101","journal-title":"PLoS Biol"},{"issue":"26","key":"2809_CR27","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","volume":"31","author":"Z Xiang","year":"2011","unstructured":"Xiang Z, Valenza M, Cui L, Leoni V, Jeong HK, Brilli E, Zhang J, Peng Q, Duan W, Reeves SA, Cattaneo E, Krainc D (2011) Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of\u00a0Huntington\u2019s disease. J Neurosci 31(26):9544\u20139553","journal-title":"J Neurosci"},{"key":"2809_CR28","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799\u20132809","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2809_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of\u00a0PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127(1):59\u201369","journal-title":"Cell"},{"issue":"5","key":"2809_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD, Cui L, Beyer RP, Easley CN, Smith AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, La Spada AR (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4(5):349\u2013362","journal-title":"Cell Metab"},{"key":"2809_CR31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A, Kaul M, Graham RK, Zhang D, Chen H-SV, Tong G, Hayden MR, Lipton SA (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 15:1407\u20131414","journal-title":"Nat Med"},{"key":"2809_CR32","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M, Sassone J, Ciammola A, Squitieri F, Beal MF (2009) Impaired PGC-1alpha function in muscle in Huntington\u2019s disease. Hum Mol Genet 18:3048\u20133065","journal-title":"Hum Mol Genet"},{"key":"2809_CR33","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","volume":"19","author":"RK Chaturvedi","year":"2010","unstructured":"Chaturvedi RK, Calingasan NY, Yang L, Hennessey T, Johri A, Beal MF (2010) Impairment of PGC- 1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington\u2019s Disease following chronic energy deprivation. Hum Mol Genet 19:3190\u20133205","journal-title":"Hum Mol Genet"},{"issue":"33","key":"2809_CR34","doi-asserted-by":"crossref","first-page":"30843","DOI":"10.1074\/jbc.M303643200","volume":"278","author":"J Lin","year":"2003","unstructured":"Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM (2003) PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem 278(33):30843\u201330848","journal-title":"J Biol Chem"},{"key":"2809_CR35","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormeir K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19:3919\u20133935","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2809_CR36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","volume":"20","author":"E Martin","year":"2011","unstructured":"Martin E, Betuing S, Pag\u00e8s C, Cambon K, Auregan G, Deglon N, Roze E, Caboche J (2011) Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington\u2019s disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet 20(12):2422\u20132434","journal-title":"Hum Mol Genet"},{"key":"2809_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by thePGC-1 transcriptionalcoactivators. Cell 127:397\u2013408","journal-title":"Cell"},{"key":"2809_CR38","doi-asserted-by":"crossref","first-page":"14297","DOI":"10.1126\/scitranslmed.3003799","volume":"4","author":"T Tsunemi","year":"2012","unstructured":"Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1a rescues Huntington\u2019s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4:14297","journal-title":"Sci Transl Med"},{"key":"2809_CR39","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","volume":"100","author":"C Handschin","year":"2003","unstructured":"Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 100:7111\u20137116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"2809_CR40","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","volume":"284","author":"P Wareski","year":"2009","unstructured":"Wareski P, Vaarmann A, Choubey V, Safiulina D, Liiv J, Kuum M, Kaasik A (2009) PGC-1\u03b1 and PGC-1\u03b2 regulate mitochondrial density in neurons. J Biol Chem 284(32):21379\u201321385","journal-title":"J Biol Chem"},{"issue":"4","key":"2809_CR41","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/ejn.13275","volume":"44","author":"M Lee","year":"2016","unstructured":"Lee M, Liu T, Im W, Kim M (2016) Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington\u2019s disease in vitro model. Eur J Neurosci 44(4):2114\u20132119","journal-title":"Eur J Neurosci"},{"key":"2809_CR42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fnins.2018.00778","volume":"12","author":"Y Fujita","year":"2018","unstructured":"Fujita Y, Yamashita T (2018) Sirtuins in neuroendocrine regulation and neurological diseases. Front Neurosci 12:778","journal-title":"Front Neurosci"},{"key":"2809_CR43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2018.10.028","volume":"161","author":"Y Wang","year":"2019","unstructured":"Wang Y, He J, Liao M, Hu M, Li W, Ouyang H, Wang X, Ye T, Zhang Y, Ouyang L (2019) An overview of\u00a0Sirtuins\u00a0as potential therapeutic target: structure, function and modulators. Eur J Med Chem 161:48\u201377","journal-title":"Eur J Med Chem"},{"key":"2809_CR44","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2008.04.065","volume":"154","author":"M Pallas","year":"2008","unstructured":"Pallas M, Pizarro JG, Gutierrez-Cuesta J, Crespo-Biel N, Alvira D, Tajes M, Yeste- Velasco M, Folch J, Canudas AM, Sureda FX, Ferrer I, Camins A (2008) Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neurosci 154:1388\u20131397","journal-title":"Neurosci"},{"issue":"1","key":"2809_CR45","doi-asserted-by":"crossref","first-page":"e0145425","DOI":"10.1371\/journal.pone.0145425","volume":"11","author":"R Tulino","year":"2016","unstructured":"Tulino R, Benjamin AC, Jolinon N, Smith DL, Chini EN, Carnemolla A, Bates GP (2016) SIRT1 activity is linked to its brain region-specific phosphorylation and is impaired in Huntington\u2019s disease mice. PLoS ONE 11(1):e0145425","journal-title":"PLoS ONE"},{"key":"2809_CR46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.2559","volume":"18","author":"H Jeong","year":"2011","unstructured":"Jeong H, Cohen DE, Cui L, Supinski A, Savas JN, Mazzulli JR, Yates JR 3rd, Bordone L, Guarente L, Krainc D (2011) Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med 18:159\u2013165","journal-title":"Nat Med"},{"key":"2809_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2011","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H et al (2011) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18:153\u2013158","journal-title":"Nat Med"},{"issue":"8","key":"2809_CR48","doi-asserted-by":"crossref","first-page":"e22966","DOI":"10.1371\/journal.pone.0022966","volume":"6","author":"C Zuccato","year":"2011","unstructured":"Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-L\u00e8vi AC, Tabrizi SJ, Di Donato S, Cattaneo E (2011) Brain-derived neurotrophic factor\u00a0in patients with Huntington\u2019s disease. PLoS ONE 6(8):e22966","journal-title":"PLoS ONE"},{"key":"2809_CR49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ncomms2238","volume":"3","author":"A Cheng","year":"2012","unstructured":"Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X, Luo Y, Okun E, Mattson MP (2012) Involvement of\u00a0PGC-1\u03b1 in the formation and maintenance of neuronal dendritic spines. Nat Commun 3:1250","journal-title":"Nat Commun"},{"key":"2809_CR50","doi-asserted-by":"crossref","first-page":"12630","DOI":"10.1523\/JNEUROSCI.0277-12.2012","volume":"32","author":"JA Parker","year":"2012","unstructured":"Parker JA, Vasquez-Manrique RP, Tourette C, Farina F, Offner N, Mukhopadhyay A, Orfila AM, Darbois A, Menet S, Tissenbaum H, Neri C (2012) Integration of beta-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin TOXICITY. J Neurosci 32:12630\u201312640","journal-title":"J Neurosci"},{"issue":"5","key":"2809_CR51","doi-asserted-by":"crossref","first-page":"e0195968","DOI":"10.1371\/journal.pone.0195968","volume":"13","author":"M Lee","year":"2018","unstructured":"Lee M, Ban J-J, Chung J-Y, Im W, Kim M (2018) Amelioration of Huntington\u2019s disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1\u03b1 deacetylation. PLoS ONE 13(5):e0195968","journal-title":"PLoS ONE"},{"key":"2809_CR52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","volume":"37","author":"JA Parker","year":"2005","unstructured":"Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37:349\u2013350","journal-title":"Nat Genet"},{"issue":"6","key":"2809_CR53","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol\u00a0improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6):1109\u20131122","journal-title":"Cell"},{"issue":"1","key":"2809_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","volume":"225","author":"DJ Ho","year":"2010","unstructured":"Ho DJ, Calingasan NY, Wille E, Dumont M, Beal MF (2010) Resveratrol\u00a0protects against peripheral deficits in a mouse model of Huntington\u2019s disease. Exp Neurol 225(1):74\u201384. https:\/\/doi.org\/10.1016\/j.expneurol.2010.05.006","journal-title":"Exp Neurol"},{"issue":"7","key":"2809_CR55","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","volume":"54","author":"L Naia","year":"2017","unstructured":"Naia L, Rosenstock TR, Oliveira AM, Oliveira-Sousa SI, Caldeira GL, Carmo C, La\u00e7o MN, Hayden MR, Oliveira CR, Rego AC (2017) Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington\u2019s disease models. Mol Neurobiol 54(7):5385\u20135399","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2809_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","volume":"41","author":"T Hathorn","year":"2011","unstructured":"Hathorn T, Snyder-Keller A, Messer A (2011) Nicotinamide improves motor deficits and upregulates PGC-1\u03b1 and BDNF gene expression in a mouse model of Huntington\u2019s disease. Neurobiol Dis 41(1):43\u201350","journal-title":"Neurobiol Dis"},{"issue":"6","key":"2809_CR57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.410360613","volume":"36","author":"MF Beal","year":"1994","unstructured":"Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36(6):882\u2013888","journal-title":"Ann Neurol"},{"key":"2809_CR58","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","volume":"74","author":"ES Hwang","year":"2017","unstructured":"Hwang ES, Song SB (2017) Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci 74:3347","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2809_CR59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","volume":"137","author":"H Jeong","year":"2009","unstructured":"Jeong H, Then F, Melia TJ Jr, Mazzulli JR, Cui L, Savas JN, Voisine C, Paganetti P, Tanese N, Hart AC, Yamamoto A, Krainc D (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137(1):60\u201372","journal-title":"Cell"},{"issue":"23","key":"2809_CR60","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","volume":"17","author":"J Pallos","year":"2008","unstructured":"Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL (2008) Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet 17(23):3767\u20133775","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2809_CR61","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","volume":"33","author":"A Sidhu","year":"2018","unstructured":"Sidhu A, Diwan V, Kaur H, Bhateja D, Singh CK, Sharma S, Padi SSV (2018) Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model of Huntington\u2019s disease: implication of oxidative stress-poly(ADP-ribose) polymerase pathway. Metab Brain Dis 33(6):1911\u20131921","journal-title":"Metab Brain Dis"},{"key":"2809_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2018.07.001","author":"Y Sasaki","year":"2018","unstructured":"Sasaki Y (2018) Metabolic aspects of neuronal degeneration: from a NAD+ point of view. Neurosci Res. https:\/\/doi.org\/10.1016\/j.neures.2018.07.001","journal-title":"Neurosci Res"},{"issue":"11","key":"2809_CR63","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","volume":"23","author":"MR Smith","year":"2014","unstructured":"Smith MR, Syed A, Lukacsovich T, Purcell J, Barbaro BA, Worthge SA, Wei SR, Pollio G, Magnoni L, Scali C, Massai L, Franceschini D, Camarri M, Gianfriddo M, Diodato E, Thomas R, Gokce O, Tabrizi SJ, Caricasole A, Landwehrmeyer B, Menalled L, Murphy C, Ramboz S, Luthi-Carter R, Westerberg G, Marsh JL (2014) A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease. Hum Mol Genet 23(11):2995\u20133007","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2809_CR64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bcp.12513","volume":"79","author":"G Westerberg","year":"2015","unstructured":"Westerberg G, Chiesa JA, Andersen CA, Diamanti D, Magnoni L, Pollio G, Darpo B, Zhou M (2015) Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1inhibitor selisistat in healthy volunteers. Br J Clin Pharmacol 79(3):477\u2013491","journal-title":"Br J Clin Pharmacol"},{"key":"2809_CR65","first-page":"A102","volume":"85","author":"R Reilmann","year":"2014","unstructured":"Reilmann R, Squitieri F, Priller J et al (2014) N02 Safety and tolerability of selisistat for the treatment of huntington\u2019s disease: results from a randomised, double-blind, Placebo-controlled Phase Ii Trial. J Neurol Neurosurg Psychiatry 85:A102","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2809_CR66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bcp.12512","volume":"79","author":"SD S\u00fcssmuth","year":"2015","unstructured":"S\u00fcssmuth SD, Haider S, Landwehrmeyer GB et al (2015) An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington\u2019s disease. Br J Clin Pharmacol 79(3):465\u2013476","journal-title":"Br J Clin Pharmacol"},{"key":"2809_CR67","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.1111308108","volume":"108","author":"E Jing","year":"2011","unstructured":"Jing E, Emanuelli B, Hirschey MD, Boucher J, Lee KY, Lombard D, Verdin EM, Kahn CR (2011) Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci U S A 108:14608\u201314613","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2809_CR68","doi-asserted-by":"crossref","first-page":"914","DOI":"10.18632\/aging.100252","volume":"2","author":"AV Hafner","year":"2010","unstructured":"Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA (2010) Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2:914\u2013923","journal-title":"Aging"},{"issue":"6","key":"2809_CR69","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2007.07.035","volume":"130","author":"H Yang","year":"2007","unstructured":"Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, de Cabo R, Sauve AA, Sinclair DA (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130(6):1095\u20131107","journal-title":"Cell"},{"key":"2809_CR70","doi-asserted-by":"crossref","first-page":"e14731","DOI":"10.1371\/journal.pone.0014731","volume":"6","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lu HF, Alano CC (2011) Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture. PLoS ONE 6:e14731","journal-title":"PLoS ONE"},{"key":"2809_CR71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/bi901627u","volume":"49","author":"H Cimen","year":"2010","unstructured":"Cimen H, Han MJ, Yang Y, Tong Q, Koc H (2010) Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49:304\u2013311","journal-title":"Biochemistry"},{"key":"2809_CR72","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3- mediated SOD2 activation. Cell Metab 12:662\u2013667","journal-title":"Cell Metab"},{"key":"2809_CR73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.molcel.2010.12.013","volume":"40","author":"R Tao","year":"2010","unstructured":"Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D (2010) Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 40:893\u2013904","journal-title":"Mol Cell"},{"key":"2809_CR74","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/embor.2011.65","volume":"12","author":"Y Chen","year":"2011","unstructured":"Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S, Xiong Y (2011) Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 12:534\u2013541","journal-title":"EMBO Rep"},{"key":"2809_CR75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, Stevens RD, Muehlbauer MJ, Kakar S, Bass NM, Kuusisto J, Laakso M, Alt FW, Newgard CB, Farese RV Jr, Kahn CR, Verdin E (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44:177\u2013190","journal-title":"Mol Cell"},{"issue":"3","key":"2809_CR76","doi-asserted-by":"crossref","first-page":"e0118909","DOI":"10.1371\/journal.pone.0118909","volume":"10","author":"T Chen","year":"2015","unstructured":"Chen T, Liu J, Li N, Wang S, Liu H, Li J, Zhang Y, Bu P (2015) Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS ONE 10(3):e0118909","journal-title":"PLoS ONE"},{"issue":"5","key":"2809_CR77","doi-asserted-by":"crossref","first-page":"e0125617","DOI":"10.1371\/journal.pone.0125617","volume":"10","author":"TE Akie","year":"2015","unstructured":"Akie TE, Liu L, Nam M, Lei S, Cooper MP (2015) OXPHOS-mediated induction of NAD+ promotes complete oxidation of fatty acids and interdicts non-alcoholic fatty liver disease. PLoS ONE 10(5):e0125617","journal-title":"PLoS ONE"},{"issue":"4","key":"2809_CR78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","volume":"110","author":"C Koentges","year":"2015","unstructured":"Koentges C, Pfeil K, Schnick T, Wiese S, Dahlbock R, Cimolai MC, Meyer-Steenbuck M, Cenkerova K, Hoffmann MM, Jaeger C, Odening KE, Kammerer B, Hein L, Bode C, Bugger H (2015) SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol 110(4):36","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"2809_CR79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygeno.2004.11.003","volume":"85","author":"D Bellizzi","year":"2005","unstructured":"Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85(2):258\u2013263","journal-title":"Genomics"},{"key":"2809_CR80","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","volume":"143","author":"S Someya","year":"2010","unstructured":"Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:802\u2013812","journal-title":"Cell"},{"issue":"1","key":"2809_CR81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cmet.2015.10.013","volume":"23","author":"A Cheng","year":"2016","unstructured":"Cheng A, Yang Y, Zhou Y, Maharana C, Lu D, Peng W, Liu Y, Wan R, Marosi K, Misiak M, Bohr VA, Mattson MP (2016) Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab 23(1):128\u2013142","journal-title":"Cell Metab"},{"issue":"10","key":"2809_CR82","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13(10):4181\u20134192","journal-title":"J Neurosci"},{"issue":"6","key":"2809_CR83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","volume":"8","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P (1995) Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Curr Opin Neurol 8(6):469\u2013473","journal-title":"Curr Opin Neurol"},{"key":"2809_CR84","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1074\/jbc.M112.382226","volume":"287","author":"J Fu","year":"2012","unstructured":"Fu J, Jin J, Cichewicz RH, Hageman SA, Ellis TK, Xiang L, Peng Q, Jiang M, Arbez N, Hotaling K, Ross CA, Duan W (2012) trans-(-)-eViniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem 287:24460\u201324472","journal-title":"J Biol Chem"},{"issue":"7","key":"2809_CR85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","volume":"13","author":"BA Gibson","year":"2012","unstructured":"Gibson BA, Kraus WL (2012) New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13(7):411\u2013424","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2809_CR86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1196\/annals.1427.014","volume":"1147","author":"SA Andrabi","year":"2008","unstructured":"Andrabi SA, Dawson TM, Dawson VL (2008) Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci 1147:233\u2013241","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2809_CR87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15698\/mic2016.03.483","volume":"3","author":"L Galluzzi","year":"2016","unstructured":"Galluzzi L, Kepp O, Kroemer G (2016) Mitochondrial regulation of cell death: a phylogenetically conserved control. Microb Cell 3(3):101\u2013108","journal-title":"Microb Cell"},{"key":"2809_CR88","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbadis.2009.08.010","volume":"1801","author":"GE Gibson","year":"2010","unstructured":"Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF (2010) Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 1801:122\u2013134","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2809_CR89","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342(3):619\u2013630","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2809_CR90","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.25835","volume":"29","author":"A Chandra","year":"2014","unstructured":"Chandra A, Johri A, Beal MF (2014) Prospects for neuroprotective therapies in prodromal Huntington\u2019s disease. Mov Disord 29(3):285\u2013293","journal-title":"Mov Disord"},{"issue":"3","key":"2809_CR91","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bbrc.2007.03.163","volume":"357","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Grammatopoulos TN, Altmann S, Amore A, Standaert DG, Hyman BT, Kazantsev AG (2007) Pharmacological inhibition of\u00a0PARP-1 reduces alpha-synuclein- and MPP+ -induced cytotoxicity in Parkinson\u2019s disease in vitro models. Biochem Biophys Res Commun 357(3):596\u2013602","journal-title":"Biochem Biophys Res Commun"},{"key":"2809_CR92","doi-asserted-by":"crossref","first-page":"e2166","DOI":"10.1038\/cddis.2016.72","volume":"7","author":"S Lehmann","year":"2016","unstructured":"Lehmann S, Costa AC, Celardo I, Loh SH, Martins LM (2016) Parp\u00a0mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson\u2019s disease. Cell Death Dis 7:e2166","journal-title":"Cell Death Dis"},{"issue":"6414","key":"2809_CR93","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1126\/science.aat8407","volume":"362","author":"TI Kam","year":"2018","unstructured":"Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL (2018) Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science 362(6414):8407","journal-title":"Science"},{"issue":"1","key":"2809_CR94","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","volume":"6","author":"L McGurk","year":"2018","unstructured":"McGurk L, Mojsilovic-Petrovic J, Van Deerlin VM, Shorter J, Kalb RG, Lee VM, Trojanowski JQ, Lee EB, Bonini NM (2018) Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis. Acta Neuropathol Commun 6(1):84","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2809_CR95","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-151040","volume":"54","author":"S Martire","year":"2016","unstructured":"Martire S, Fuso A, Mosca L, Forte E, Correani V, Fontana M, Scarpa S, Maras B, d\u2019Erme M (2016) Bioenergetic impairment in animal and cellular models of Alzheimer\u2019s disease: PARP-1 inhibition rescues metabolic dysfunctions. J Alzheimers Dis 54(1):307\u2013324","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2809_CR96","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exnr.2001.7633","volume":"168","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Friedlich A, Ferrante KL, Hughes D, Szabo C, Beal MF (2001) Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp Neurol 168(2):419\u2013424","journal-title":"Exp Neurol"},{"issue":"2","key":"2809_CR97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DT (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun 359(2):335\u2013340","journal-title":"Biochem Biophys Res Commun"},{"key":"2809_CR98","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","volume":"286","author":"S Hands","year":"2011","unstructured":"Hands S, Sajjad MU, Newton MJ, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286:44512\u201344520","journal-title":"J Biol Chem"},{"issue":"23","key":"2809_CR99","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1091\/mbc.E18-09-0590","volume":"29","author":"CL Hung","year":"2018","unstructured":"Hung CL, Maiuri T, Bowie LE, Gotesman R, Son S, Falcone M, Giordano JV, Gillis T, Mattis V, Lau T, Kwan V, Wheeler V, Schertzer J, Singh K, Truant R (2018) A patient-derived cellular model for Huntington\u2019s disease reveals phenotypes at clinically relevant CAG lengths. Mol Biol Cell 29(23):2809\u20132820","journal-title":"Mol Biol Cell"},{"key":"2809_CR100","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1517\/13543776.2011","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8:2061\u20132073. https:\/\/doi.org\/10.1517\/13543776.2011","journal-title":"Antioxid Redox Signal"},{"key":"2809_CR101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","volume":"62","author":"S Ayala-Pe\u00f1a","year":"2013","unstructured":"Ayala-Pe\u00f1a S (2013) Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis. Free Radic Biol Med 62:102\u2013110","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2809_CR102","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11011-018-0308-1","volume":"33","author":"P J\u0119drak","year":"2018","unstructured":"J\u0119drak P, Mozolewski P, W\u0119grzyn G, Wi\u0119ckowski MR (2018) Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington\u2019s disease patients. Metab Brain Dis 33(6):2005\u20132017","journal-title":"Metab Brain Dis"},{"issue":"1","key":"2809_CR103","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1038\/s41598-018-27985-y","volume":"8","author":"G Askeland","year":"2018","unstructured":"Askeland G, Dosoudilova Z, Rodinova M, Klempir J, Liskova I, Ku\u015bnierczyk A, Bj\u00f8r\u00e5s M, Nesse G, Klungland A, Hansikova H, Eide L (2018) Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington\u2019s disease patients. Sci Rep 8(1):9817","journal-title":"Sci Rep"},{"issue":"6","key":"2809_CR104","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington\u2019s disease. J Neurochem 79(6):1246\u20131249","journal-title":"J Neurochem"},{"key":"2809_CR105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1242\/dmm.035949","volume":"1","author":"G Askeland","year":"2018","unstructured":"Askeland G, Rodinova M, \u0160tufkov\u00e1 H, Dosoudilova Z, Baxa M, Smatlikova P, Bohuslavova B, Klempir J, Nguyen TD, Ku\u015bnierczyk A, Bj\u00f8r\u00e5s M, Klungland A, Hansikova H, Ellederova Z, Eide L (2018) A transgenic minipig model of Huntington\u2019s disease shows early signs of behavioral and molecular pathologies. Dis Model Mech 1:2. https:\/\/doi.org\/10.1242\/dmm.035949","journal-title":"Dis Model Mech"},{"issue":"3","key":"2809_CR106","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","volume":"109","author":"JC Vis","year":"2005","unstructured":"Vis JC, Schipper E, de Boer-van Huizen RT, Verbeek MM, de Waal RM, Wesseling P, ten Donkelaar HJ, Kremer B (2005) Expression pattern of apoptosis-related markers in Huntington\u2019s disease. Acta Neuropathol 109(3):321\u2013328","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2809_CR107","doi-asserted-by":"crossref","first-page":"e0134482","DOI":"10.1371\/journal.pone.0134482","volume":"10","author":"A Cardinale","year":"2015","unstructured":"Cardinale A, Paldino E, Giamp\u00e0 C, Bernardi G, Fusco FR (2015) PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 10(8):e0134482","journal-title":"PLoS ONE"},{"key":"2809_CR108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnana.2017.00061","volume":"11","author":"E Paldino","year":"2017","unstructured":"Paldino E, Cardinale A, D\u2019Angelo V, Sauve I, Giamp\u00e0 C, Fusco FR (2017) Selective sparing of striatal interneurons after poly (ADP-ribose) polymerase 1 inhibition in the R6\/2 mouse model of Huntington\u2019s disease. Front Neuroanat 11:61","journal-title":"Front Neuroanat"},{"key":"2809_CR109","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1101\/gad.1467506","volume":"20","author":"MC Haigis","year":"2006","unstructured":"Haigis MC, Guarente LP (2006) Mammalian sirtuins\u2013emerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913\u20132921","journal-title":"Genes Dev"},{"issue":"7029","key":"2809_CR110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113\u2013118","journal-title":"Nature"},{"issue":"7","key":"2809_CR111","doi-asserted-by":"crossref","first-page":"e11707","DOI":"10.1371\/journal.pone.0011707","volume":"5","author":"X Kong","year":"2010","unstructured":"Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F, Chang Y (2010) Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 5(7):e11707","journal-title":"PLoS ONE"},{"issue":"6","key":"2809_CR112","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.mam.2013.01.004","volume":"34","author":"C Cant\u00f3","year":"2013","unstructured":"Cant\u00f3 C, Sauve AA, Bai P (2013) Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med 34(6):1168\u20131201","journal-title":"Mol Aspects Med"},{"issue":"5","key":"2809_CR113","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bcp.2011.12.014","volume":"83","author":"K M\u00f3dis","year":"2012","unstructured":"M\u00f3dis K, Gero D, Erd\u00e9lyi K, Szoleczky P, DeWitt D, Szabo C (2012) Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem Pharmacol 83(5):633\u2013643","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2809_CR114","doi-asserted-by":"crossref","first-page":"e0134227","DOI":"10.1371\/journal.pone.0134227","volume":"10","author":"G Ol\u00e1h","year":"2015","unstructured":"Ol\u00e1h G, Szczesny B, Bruny\u00e1nszki A, L\u00f3pez-Garc\u00eda IA, Ger\u00f6 D, Rad\u00e1k Z, Szabo C (2015) Differentiation-associated downregulation of poly(ADP-ribose) polymerase-1 expression in myoblasts serves to increase their resistance to oxidative stress. PLoS ONE 10(7):e0134227","journal-title":"PLoS ONE"},{"issue":"4","key":"2809_CR115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P, Cant\u00f3 C, Bruny\u00e1nszki A, Huber A, Sz\u00e1nt\u00f3 M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Menissier-de Murcia J, Schreiber V, Sauve AA, Auwerx J (2011) PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13(4):450\u2013460","journal-title":"Cell Metab"},{"issue":"4","key":"2809_CR116","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P, Cant\u00f3 C, Oudart H, Bruny\u00e1nszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461\u2013468","journal-title":"Cell Metab"},{"key":"2809_CR117","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/STROKEAHA.107.509158","volume":"39","author":"S Wang","year":"2008","unstructured":"Wang S, Xing Z, Vosler PS, Yin H, Li W, Zhang F, Signore AP, Stetler RA, Gao Y, Chen J (2008) Cellular NAD replenishment confers marked neuroprotection against ischemic cell death role of enhanced DNA repair. Stroke 39:2587\u20132595","journal-title":"Stroke"},{"key":"2809_CR118","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1007\/s12035-017-0809-7","volume":"55","author":"Q Huang","year":"2018","unstructured":"Huang Q, Sun M, Li M et al (2018) Combination of NAD+ and NADPH offers greater neuroprotection in ischemic stroke models by relieving metabolic stress. Mol Neurobiol 55:6063","journal-title":"Mol Neurobiol"},{"issue":"6","key":"2809_CR119","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/mol.111.073916","volume":"80","author":"M Pittelli","year":"2011","unstructured":"Pittelli M, Felici R, Pitozzi V, Giovannelli L, Bigagli E, Cialdai F, Romano G, Moroni F, Chiarugi A (2011) Exogenous NAD and cytoprotection. Mol Pharmacol 80(6):1136\u20131146","journal-title":"Mol Pharmacol"},{"issue":"12","key":"2809_CR120","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s007020070011","volume":"107","author":"M Rainer","year":"2000","unstructured":"Rainer M, Kraxberger E, Haushofer M, Mucke HA, Jellinger KA (2000) No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia. J Neural Transm 107(12):1475\u20131481","journal-title":"J Neural Transm"},{"issue":"4","key":"2809_CR121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002512-199813040-00002","volume":"13","author":"RH Swerdlow","year":"1998","unstructured":"Swerdlow RH (1998) Is NADH effective in the treatment of Parkinson\u2019s disease? Drugs Aging 13(4):263\u2013268","journal-title":"Drugs Aging"},{"key":"2809_CR122","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02263483","volume":"4","author":"W Birkmayer","year":"1989","unstructured":"Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E (1989) The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. J Neural Transm Park Dis Dement Sect. 4:297\u2013302","journal-title":"J Neural Transm Park Dis Dement Sect."},{"key":"2809_CR123","first-page":"545","volume":"53","author":"W Birkmayer","year":"1990","unstructured":"Birkmayer W, Birkmayer JG, Vrecko K, Paletta B (1990) The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Adv Neurol 53:545\u2013549","journal-title":"Adv Neurol"},{"key":"2809_CR124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0404.1993.tb00018.x","volume":"146","author":"JG Birkmayer","year":"1993","unstructured":"Birkmayer JG, Vrecko C, Volc D, Birkmayer W (1993) Nicotinamide adenine dinucleotide (NADH)\u2013a new therapeutic approach to Parkinson\u2019s disease. Comparison of oral and parenteral application. Acta Neurol Scand Suppl 146:32\u201335","journal-title":"Acta Neurol Scand Suppl"},{"issue":"5","key":"2809_CR125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0404.1994.tb02735.x","volume":"90","author":"N Dizdar","year":"1994","unstructured":"Dizdar N, K\u00e5gedal B, Lindvall B (1994) Treatment of Parkinson\u2019s disease with NADH. Acta Neurol Scand 90(5):345\u2013347","journal-title":"Acta Neurol Scand"},{"issue":"5\u20136","key":"2809_CR126","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10284150500484638","volume":"8","author":"JM Alisky","year":"2005","unstructured":"Alisky JM (2005) Niacin improved rigidity and bradykinesia in a Parkinson\u2019s disease patient but also caused unacceptable nightmares and skin rash\u2013a case report. Nutr Neurosci 8(5\u20136):327\u2013329","journal-title":"Nutr Neurosci"},{"key":"2809_CR127","doi-asserted-by":"crossref","first-page":"021","DOI":"10.23937\/2469-5858\/1510021","volume":"3","author":"MJ Phelan","year":"2017","unstructured":"Phelan MJ, Mulnard RA, Gillen DL, Schreiber SS (2017) Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer\u2019s disease. J Geriatr Med Gerontol 3:021","journal-title":"J Geriatr Med Gerontol"},{"issue":"45","key":"2809_CR128","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM (2008) Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28(45):11500\u201311510","journal-title":"J Neurosci"},{"key":"2809_CR129","doi-asserted-by":"crossref","first-page":"117864691877665","DOI":"10.1177\/1178646918776658","volume":"11","author":"RA Fricker","year":"2018","unstructured":"Fricker RA, Green EL, Jenkins SI, Griffin SM (2018) The influence of nicotinamide on health and disease in the central nervous system. Int J Tryptophan Res 11:1178646918776658","journal-title":"Int J Tryptophan Res"},{"issue":"4","key":"2809_CR130","doi-asserted-by":"crossref","first-page":"E974","DOI":"10.3390\/ijms20040974","volume":"20","author":"V Gasperi","year":"2019","unstructured":"Gasperi V, Sibilano M, Savini I, Catani MV (2019) Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci 20(4):E974","journal-title":"Int J Mol Sci"},{"key":"2809_CR131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2007.03.024","volume":"129","author":"P Belenky","year":"2007","unstructured":"Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C (2007) Nicotinamide rioside promotes Sir2 silencing and extends lifespan via Nrk and Urh1\/Pnp1\/Meu1 pathways to NAD+. Cell 129:473\u2013484","journal-title":"Cell"},{"issue":"6292","key":"2809_CR132","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","volume":"352","author":"H Zhang","year":"2016","unstructured":"Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, D\u2019Amico D, Ropelle ER, Lutolf MP, Aebersold R, Schoonjans K, Menzies KJ, Auwerx J (2016) NAD+ repletion improves mitochondrial and stem cell function and enhances life span in\u00a0mice. Science 352(6292):1436\u20131443","journal-title":"Science"},{"key":"2809_CR133","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","volume":"117","author":"P Bieganowski","year":"2004","unstructured":"Bieganowski P, Brenner C (2004) Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD \u00fe in fungi and humans. Cell 117:495\u2013502","journal-title":"Cell"},{"key":"2809_CR134","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1038\/ncomms13103","volume":"7","author":"J Ratajczak","year":"2016","unstructured":"Ratajczak J, Joffraud M, Trammell SA, Ras R, Canela N, Boutant M, Kulkarni SS, Rodrigues M, Redpath P, Migaud ME, Auwerx J, Yanes O, Brenner C, Cant\u00f3 C (2016) NRK1 controls nicotinamide mononucleotide and nicotinamide riboside\u00a0metabolism in mammalian cells. Nat Commun 7:13103","journal-title":"Nat Commun"},{"key":"2809_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1530\/jme-18-0085","volume":"2","author":"RS Fletcher","year":"2018","unstructured":"Fletcher RS, Lavery G (2018) The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism. J Mol Endocrinol 2:4. https:\/\/doi.org\/10.1530\/jme-18-0085","journal-title":"J Mol Endocrinol"},{"issue":"26","key":"2809_CR136","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1021\/jm701001c","volume":"50","author":"T Yang","year":"2007","unstructured":"Yang T, Chan NY, Sauve AA (2007) Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J Med Chem 50(26):6458\u20136461","journal-title":"J Med Chem"},{"key":"2809_CR137","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15:838\u2013847","journal-title":"Cell Metab"},{"issue":"6","key":"2809_CR138","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2014.11.003","volume":"20","author":"KD Brown","year":"2014","unstructured":"Brown KD, Maqsood S, Huang JY, Pan Y, Harkcom W, Li W, Sauve A, Verdin E, Jaffrey SR (2014) Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab 20(6):1059\u20131068","journal-title":"Cell Metab"},{"issue":"10","key":"2809_CR139","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","volume":"23","author":"DC Sch\u00f6ndorf","year":"2018","unstructured":"Sch\u00f6ndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK, Di Napoli G, Panagiotakopoulou V, Nestel S, Keatinge M, Pruszak J, Bandmann O, Heimrich B, Gasser T, Whitworth AJ, Deleidi M (2018) The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease. Cell Rep 23(10):2976\u20132988","journal-title":"Cell Rep"},{"key":"2809_CR140","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","volume":"34","author":"B Gong","year":"2013","unstructured":"Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, Pasinetti GM (2013) Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-\u03b3 coactivator 1\u03b1 regulated \u03b2-secretase; 1 degradation and mitochondrial gene expression in Alzheimer\u2019s mouse models. Neurobiol Aging 34:1581\u20131588","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2809_CR141","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","volume":"115","author":"Y Hou","year":"2018","unstructured":"Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau DL, Zavala E, Zhang Y, Moritoh K, O\u2019Connell JF, Baptiste BA, Stevnsner TV, Mattson MP, Bohr VA (2018) NAD+ supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A 115(8):E1876\u2013E1885","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2809_CR142","doi-asserted-by":"crossref","first-page":"e00237","DOI":"10.1128\/MCB.00237-17","volume":"37","author":"P Sykora","year":"2017","unstructured":"Sykora P, Kanno S, Akbari M, Kulikowicz T, Baptiste BA, Leandro GS, Lu H, Tian J, May A, Becker KA, Croteau DL, Wilson DM 3rd, Sobol RW, Yasui A, Bohr VA (2017) DNA polymerase beta participates in mitochondrial DNA repair. Mol Cell Biol 37(16):e00237","journal-title":"Mol Cell Biol"},{"key":"2809_CR143","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.dnarep.2017.10.011","volume":"60","author":"R Prasad","year":"2017","unstructured":"Prasad R, \u00c7a\u011flayan M, Dai DP, Nadalutti CA, Zhao ML, Gassman NR, Janoshazi AK, Stefanick DF, Horton JK, Krasich R, Longley MJ, Copeland WC, Griffith JD, Wilson SH (2017) DNA\u00a0polymerase \u03b2: a missing link of the base excision\u00a0repair\u00a0machinery in mammalian mitochondria. DNA Repair 60:77\u201388","journal-title":"DNA Repair"},{"key":"2809_CR144","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2741\/4555","volume":"22","author":"AM Whitaker","year":"2017","unstructured":"Whitaker AM, Schaich MA, Smith MR, Flynn TS, Freudenthal BD (2017) Base excision repair of oxidative DNA damage: from mechanism to disease. Front Biosci 22:1493\u20131522","journal-title":"Front Biosci"},{"issue":"16","key":"2809_CR145","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/nar\/gkm605","volume":"35","author":"L Weissman","year":"2007","unstructured":"Weissman L, Jo DG, S\u00f8rensen MM, de Souza-Pinto NC, Markesbery WR, Mattson MP, Bohr VA (2007) Defective DNA base excision repair in brain from individuals with Alzheimer\u2019s disease and amnestic mild cognitive impairment. Nucleic Acids Res 35(16):5545\u20135555","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2809_CR146","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/acel.12541","volume":"16","author":"M Misiak","year":"2017","unstructured":"Misiak M, Vergara Greeno R, Baptiste BA, Sykora P, Liu D, Cordonnier S, Fang EF, Croteau DL, Mattson MP, Bohr VA (2017) DNA\u00a0polymerase\u00a0\u03b2 decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer\u2019s disease. Aging Cell 16(1):162\u2013172","journal-title":"Aging Cell"},{"issue":"2","key":"2809_CR147","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/nar\/gku1356","volume":"43","author":"P Sykora","year":"2015","unstructured":"Sykora P, Misiak M, Wang Y, Ghosh S, Leandro GS, Liu D, Tian J, Baptiste BA, Cong WN, Brenerman BM, Fang E, Becker KG, Hamilton RJ, Chigurupati S, Zhang Y, Egan JM, Croteau DL, Wilson DM, Mattson MP, Bohr VA (2015) DNA polymerase \u03b2 deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res 43(2):943\u2013959","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"2809_CR148","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1093\/hmg\/ddw234","volume":"25","author":"LF DiGiovanni","year":"2016","unstructured":"DiGiovanni LF, Mocle AJ, Xia J, Truant R (2016) Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization. Hum Mol Genet 25(18):3937\u20133945","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2809_CR149","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW (2009) Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 64(6):828\u2013840","journal-title":"Neuron"},{"issue":"2","key":"2809_CR150","first-page":"395","volume":"26","author":"T Maiuri","year":"2017","unstructured":"Maiuri T, Mocle AJ, Hung CL, Xia J, van Roon-Mom WM, Truant R (2017) Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Hum Mol Genet 26(2):395\u2013406","journal-title":"Hum Mol Genet"},{"issue":"5218","key":"2809_CR151","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268(5218):1749\u20131753","journal-title":"Science"},{"issue":"4","key":"2809_CR152","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","volume":"24","author":"EF Fang","year":"2016","unstructured":"Fang EF, Kassahun H, Croteau DL, Scheibye-Knudsen M, Marosi K, Lu H, Shamanna RA, Kalyanasundaram S, Bollineni RC, Wilson MA, Iser WB, Wollman BN, Morevati M, Li J, Kerr JS, Lu Q, Waltz TB, Tian J, Sinclair DA, Mattson MP, Nilsen H, Bohr VA (2016) NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab 24(4):566\u2013581","journal-title":"Cell Metab"},{"key":"2809_CR153","doi-asserted-by":"crossref","first-page":"e11184","DOI":"10.7554\/eLife.11184","volume":"5","author":"R Vijayvargia","year":"2016","unstructured":"Vijayvargia R, Epand R, Leitner A, Jung TY, Shin B, Jung R, Lloret A, Singh Atwal R, Lee H, Lee JM, Aebersold R, Hebert H, Song JJ, Seong IS (2016) Huntingtin\u2019s spherical solenoid structure enables polyglutamine tract-dependent modulation of its structure and function. Elife 5:e11184","journal-title":"Elife"},{"issue":"3","key":"2809_CR154","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","volume":"17","author":"YN Rui","year":"2015","unstructured":"Rui YN, Xu Z, Patel B, Chen Z, Chen D, Tito A, David G, Sun Y, Stimming EF, Bellen HJ, Cuervo AM, Zhang S (2015) Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol 17(3):262\u2013275","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2809_CR155","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jmg.30.12.982","volume":"30","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, Gray J, Conneally PM, Young A, Penney J et al (1993) Gametic but not somatic instability of CAG repeat length in Huntington\u2019s\u00a0disease. J Med Genet 30(12):982\u2013986","journal-title":"J Med Genet"},{"issue":"12","key":"2809_CR156","doi-asserted-by":"crossref","first-page":"e1000749","DOI":"10.1371\/journal.pgen.1000749","volume":"5","author":"A-V Goula","year":"2009","unstructured":"Goula A-V, Berquist BR, Wilson DM III, Wheeler VC, Trottier Y, Merienne K (2009) Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington\u2019s disease transgenic mice. PLoS Genet 5(12):e1000749","journal-title":"PLoS Genet"},{"issue":"1","key":"2809_CR157","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","volume":"33","author":"E Dragileva","year":"2009","unstructured":"Dragileva E, Hendricks A, Teed A, Gillis T, Lopez ET, Friedberg EC, Kucherlapati R, Edelmann W, Lunetta KL, MacDonald ME, Wheeler VC (2009) Intergenerational and striatal CAG repeat instability in Huntington\u2019s disease knock-in mice involve different DNA repair genes. Neurobiol Dis 33(1):37\u201347","journal-title":"Neurobiol Dis"},{"issue":"16","key":"2809_CR158","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami M, Hendricks AE, Gillis T, Massood T, Mysore J, Myers RH, Wheeler VC (2009) Somatic expansion of the Huntington\u2019s\u00a0disease\u00a0CAG repeat in the brain is associated with an earlier age of\u00a0disease\u00a0onset. Hum Mol Genet 18(16):3039\u20133047","journal-title":"Hum Mol Genet"},{"issue":"7143","key":"2809_CR159","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447(7143):447\u2013452","journal-title":"Nature"},{"key":"2809_CR160","doi-asserted-by":"crossref","first-page":"26631","DOI":"10.1074\/jbc.M109.034405","volume":"284","author":"A Lopez-Castel","year":"2009","unstructured":"Lopez-Castel A, Tomkinson AE, Pearson CE (2009) CTG\/CAG repeat instability is modulated by the levels of human DNA ligase I and its interaction with PCNA: a distinction between replication and slipped-DNA repair. J Biol Chem 284:26631\u201326645","journal-title":"J Biol Chem"},{"issue":"18","key":"2809_CR161","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1021\/bi300410d","volume":"51","author":"AV Goula","year":"2012","unstructured":"Goula AV, Pearson CE, Della Maria J, Trottier Y, Tomkinson AE, Wilson DM, Merienne K (2012) The nucleotide sequence, DNA damage location, and protein stoichiometry influence the base excision repair outcome at CAG\/CTG repeats. Biochemistry 51(18):3919\u20133932","journal-title":"Biochemistry"},{"issue":"41","key":"2809_CR162","doi-asserted-by":"crossref","first-page":"28352","DOI":"10.1074\/jbc.M109.050286","volume":"284","author":"Y Liu","year":"2009","unstructured":"Liu Y, Prasad R, Beard WA, Hou EW, Horton JK, McMurray CT, Wilson SH (2009) Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion. J Biol Chem 284(41):28352\u201328366","journal-title":"J Biol Chem"},{"issue":"7635","key":"2809_CR163","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature20790","volume":"541","author":"NC Hoch","year":"2017","unstructured":"Hoch NC, Hanzlikova H, Rulten SL, T\u00e9treault M, Komulainen E, Ju L, Hornyak P, Zeng Z, Gittens W, Rey SA, Staras K, Mancini GM, McKinnon PJ, Wang ZQ, Wagner JD, Yoon G, Caldecott KW, Care4Rare Canada Consortium (2017) XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature 541(7635):87\u201391","journal-title":"Nature"},{"issue":"12","key":"2809_CR164","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1096\/fj.201700221RR","volume":"31","author":"P Vaur","year":"2017","unstructured":"Vaur P, Brugg B, Mericskay M, Li Z, Schmidt MS, Vivien D, Orset C, Jacotot E, Brenner C, Duplus E (2017) Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration. FASEB J 31(12):5440\u20135452","journal-title":"FASEB J"},{"issue":"20","key":"2809_CR165","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1074\/jbc.M115.698779","volume":"291","author":"BA Harlan","year":"2016","unstructured":"Harlan BA, Pehar M, Sharma DR, Beeson G, Beeson CC, Vargas MR (2016) Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1). J Biol Chem 291(20):10836\u201310846","journal-title":"J Biol Chem"},{"issue":"11","key":"2809_CR166","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0960327115626254","volume":"35","author":"DB Conze","year":"2016","unstructured":"Conze DB, Crespo-Barreto J, Kruger CL (2016) Safety assessment of\u00a0nicotinamide riboside, a form of vitamin B3. Hum Exp Toxicol 35(11):1149\u20131160","journal-title":"Hum Exp Toxicol"},{"key":"2809_CR167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41514-017-0016-9","volume":"3","author":"RW Dellinger","year":"2017","unstructured":"Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, Marcotulli E (2017) Repeat dose NRPT (nicotinamide riboside\u00a0and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis 3:17","journal-title":"NPJ Aging Mech Dis"},{"issue":"1","key":"2809_CR168","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR (2018) Chronic\u00a0nicotinamide riboside supplementation is well-tolerated and elevates NAD+\u00a0in healthy middle-aged and older adults. Nat Commun 9(1):1286","journal-title":"Nat Commun"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02809-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T14:23:31Z","timestamp":1663424611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":168,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2809"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02809-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}